Affiliation:
1. Scrips Pharma, Mallapur, Hyderabad-500 076, Telangana, India.
2. Department of Management, Kshatriya College of Engineering, Nizamabad-503 224, Telangana, India.
Abstract
Earlier than shielding the entire world from Covid-19, another crisis is looming around the globe due to the Monkeypox virus (MPXV). In recent times, the sudden rise of Monkeypox (MPX) epidemic cases is now a cause of concern for countries around the globe. Globally, the number of new weekly cases fell by 5% from November 14 to November 20, 2022. More than 62,000 confirmed cases have been reported to WHO from 105 countries and territories since the outbreak began few months ago, along with 23 fatalities. The current outbreak primarily affects guys who have sex with other men and is disseminated primarily via sexual contact. "Just because a condition like monkeypox seems manageable does not guarantee it will remain manageable." The poor dissimilation of knowledge about viral zoonosis, disease investigation, and scientific research about MPX outbreaks can deteriorate the current situation into a deep crisis in the near future. Hence, the present case study focuses on the origin, detection, investigation, prevention, and therapeutic measures of MPX disease in the rising situation of cases. In addition, it proposes various public health measures, policy actions to prevent the transmission of the virus, medical support, and scaling up infrastructure, which are the desperate needs of the hour.